I graduated from National University of Singapore in 1997 and obtained my membership with the Royal College of Physicians (United Kingdom) in 2002. I received my internal medicine and haematology training at the Singapore General Hospital.
In 2007, I was awarded the Singapore Government Human Manpower Development Plan (HMDP) fellowship to pursue postdoctoral training and clinical research in the field of lymphoma at Stanford University, USA. Upon my return, I served as the clinical lead for the lymphoma and myeloma services at the Singapore General Hospital and spearheaded several clinical trials examining novel approaches in treating lymphoma and multiple myeloma.
I was Assistant Professor at the Duke-NUS Graduate Medical School and received numerous grants from the National Medical Research Council, Singapore Health Foundation and the Singapore Cancer Syndicate for my research. I joined Raffles Hospital in 2011 to help set up a comprehensive haematology service and became the managing partner of the Raffles Cancer Centre and the Director of Research of Raffles Hospital. I integrated research with clinical practice, availing novel therapeutics for cancer patients failing standards of care.
Being the principal investigator of more than 40 investigator-initiated and industry-sponsored clinical studies allowed me to gain early experience with state-of-the art innovations in the treatment of blood cancers. My research has led to several international presentations and more than 100 publications in high impact factor scientific journals including numerous first-authored articles in the Lancet Oncology, Blood and the Annals of Oncology.
My expertise in lymphoma and multiple myeloma was recognised by the publication of two lead-author review articles on their respective treatment guidelines in Lancet Oncology in 2014. My work on immunotherapy in NK/T-cell lymphoma has led to its endorsement on the American NCCN cancer treatment guidelines in 2018.
I was elected into the International Myeloma Working Group in 2014 and also sit on the advisory panel of the International Myeloma Foundation’s Asia Myeloma Network. As a key opinion leader, I have delivered more than 100 invited lectures on the treatment of lymphoma and multiple myeloma at international and regional conferences and serve as an advisor to many regional and international expert panels on novel drugs development.
I am currently a board member of the Chapter of Haematologists and is appointed by the Ministry of Health as an advisor for the Residency Advisory Committee for Haematology training in Singapore. My continued affiliation with the academic hospitals allows me to contribute to post-graduate teaching, and to advise patients on participation in clinical trials for lymphoma and multiple myeloma.
Learn more about Mount Elizabeth Novena Hospital here: https://www.smarterhealth.my/hospital/mount-elizabeth-novena-hospital-singapore/
Learn more about me here: https://www.smarterhealth.my/specialist-doctor/daryl-tan/
I am excited to be here to discuss Blood Cancers. Ask me anything!
Want to ask a question? Submit your question at the bottom of this page. Don’t forget to include your name and email address to get notified when the doctor answers your question.